Answer
The safety and efficacy of fostemsavir tromethamine have not yet been established in children and adolescents under 18 years, and no dosing recommendation can be made.
Sources for this answer
- Rukobia 600 mg prolonged-release tabletsViiV Healthcare UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 6Document updated
Sources checked